Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stemulite is a brand of fitness and wellness supplements originally developed by Dr. David Summers and marketed by Metabolic Research, Inc. The product line, which includes Stemulite Fitness Formula for men and women, is marketed as a "biotechnology" solution for enhancing athletic performance, muscle recovery, and sleep quality. It claims to utilize a proprietary blend of natural ingredients, including alpha-lipoic acid, beta-glucan, and indium, to support mitochondrial function and "recruit" adult stem cells. The company gained significant attention in the late 2000s but faced regulatory challenges from the National Advertising Division (NAD) and legal disputes regarding its advertising claims. The technology was later licensed to AngioSoma, Inc., which continued to market the products under the Stemulite name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stemulite.